Michael Craig Pine, Chief Corporate Dev.&Strat. Officer at EyePoint Pharmaceuticals, Inc. (EYPT), sold 46,000 shares at $22.00 ($1.0M) on 2023-12-04, disclosed to the SEC on 2023-12-11.
Scheduled sale ($1.0M) by Chief Corporate Dev.&Strat. Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.79 | 1,000 | $21K | 2.1% |
| 2 | $22.00 | 45,000 | $990K | 97.9% |
| Total | $21.97 avg | 46,000 | $1.0M | 100% |